Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

September 2009; Volume 50,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Said, Jonathan

    1. You have access
      Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas
      Tove Olafsen, David Betting, Vania E. Kenanova, Felix B. Salazar, Pat Clarke, Jonathan Said, Andrew A. Raubitschek, John M. Timmerman and Anna M. Wu
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1500-1508; DOI: https://doi.org/10.2967/jnumed.108.060426
  2. Salazar, Felix B.

    1. You have access
      Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas
      Tove Olafsen, David Betting, Vania E. Kenanova, Felix B. Salazar, Pat Clarke, Jonathan Said, Andrew A. Raubitschek, John M. Timmerman and Anna M. Wu
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1500-1508; DOI: https://doi.org/10.2967/jnumed.108.060426
  3. Saleem, Azeem

    1. You have access
      Optimization of the Injected Activity in Dynamic 3D PET: A Generalized Approach Using Patient-Specific NECs as Demonstrated by a Series of 15O-H2O Scans
      Matthew D. Walker, Julian C. Matthews, Marie-Claude Asselin, Azeem Saleem, Clare Dickinson, Natalie Charnley, Peter J. Julyan, Patricia M. Price and Terry Jones
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1409-1417; DOI: https://doi.org/10.2967/jnumed.109.062679
  4. Santi, Ivan

    1. You have access
      Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy
      Paolo Castellucci, Chiara Fuccio, Cristina Nanni, Ivan Santi, Anna Rizzello, Filippo Lodi, Alessandro Franceschelli, Giuseppe Martorana, Fabio Manferrari and Stefano Fanti
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1394-1400; DOI: https://doi.org/10.2967/jnumed.108.061507
  5. Saran, Frank H.

    1. You have access
      Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
      Susan E. Buckley, Sarah J. Chittenden, Frank H. Saran, Simon T. Meller and Glenn D. Flux
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1518-1524; DOI: https://doi.org/10.2967/jnumed.109.064469
  6. Sarda-mantel, Laure

    1. You have access
      Molecular Imaging of Cartilage
      Laure Sarda-Mantel and Dominique Le Guludec
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1391-1393; DOI: https://doi.org/10.2967/jnumed.108.057810
  7. Scheltens, Philip

    1. You have access
      Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding
      Nelleke Tolboom, Wiesje M. van der Flier, Maqsood Yaqub, Ronald Boellaard, Nicolaas A. Verwey, Marinus A. Blankenstein, Albert D. Windhorst, Philip Scheltens, Adriaan A. Lammertsma and Bart N.M. van Berckel
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1464-1470; DOI: https://doi.org/10.2967/jnumed.109.064360
  8. Schmid, Roland M.

    1. You have access
      Imaging of Proliferation in Hepatocellular Carcinoma with the In Vivo Marker 18F-Fluorothymidine
      Florian Eckel, Ken Herrmann, Stefan Schmidt, Claudia Hillerer, Hinrich A. Wieder, Bernd-Joachim Krause, Tibor Schuster, Rupert Langer, Hans-Jürgen Wester, Roland M. Schmid, Markus Schwaiger and Andreas K. Buck
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1441-1447; DOI: https://doi.org/10.2967/jnumed.109.065896
  9. Schmidt, Stefan

    1. You have access
      Imaging of Proliferation in Hepatocellular Carcinoma with the In Vivo Marker 18F-Fluorothymidine
      Florian Eckel, Ken Herrmann, Stefan Schmidt, Claudia Hillerer, Hinrich A. Wieder, Bernd-Joachim Krause, Tibor Schuster, Rupert Langer, Hans-Jürgen Wester, Roland M. Schmid, Markus Schwaiger and Andreas K. Buck
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1441-1447; DOI: https://doi.org/10.2967/jnumed.109.065896
  10. Schuster, Tibor

    1. You have access
      Imaging of Proliferation in Hepatocellular Carcinoma with the In Vivo Marker 18F-Fluorothymidine
      Florian Eckel, Ken Herrmann, Stefan Schmidt, Claudia Hillerer, Hinrich A. Wieder, Bernd-Joachim Krause, Tibor Schuster, Rupert Langer, Hans-Jürgen Wester, Roland M. Schmid, Markus Schwaiger and Andreas K. Buck
      Journal of Nuclear Medicine September 1, 2009, 50 (9) 1441-1447; DOI: https://doi.org/10.2967/jnumed.109.065896
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 50 (9)
Journal of Nuclear Medicine
Vol. 50, Issue 9
September 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire